A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
DualityBio Inc.
DualityBio Inc.
University of Nebraska
City of Hope Medical Center
Actym Therapeutics, Inc.
Merck Sharp & Dohme LLC
Elicio Therapeutics
Shanghai Bao Pharmaceuticals Co., Ltd.
Tempus AI
Elevation Oncology
Intensity Therapeutics, Inc.
Alliance for Clinical Trials in Oncology
Carisma Therapeutics Inc
UTC Therapeutics Inc.
Celldex Therapeutics
Chongqing Precision Biotech Co., Ltd
Klus Pharma Inc.
Xencor, Inc.
MacroGenics
SpeciCare
Abramson Cancer Center at Penn Medicine
Swiss Cancer Institute
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Massachusetts General Hospital
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
NYU Langone Health
Case Comprehensive Cancer Center